Communication to Customers - 28th June, 2023

Dear MMEx Medisecure users,

We have attended a briefing this morning by DOHAC and the ADHA regarding the national e-prescribing delivery service and it has been confirmed that there will be a transitional period supporting e-prescribing from 01/07/2023 to 30/09/2023. During this time e-scripts will be valid via both MediSecure and eRx.

We are working on the integration with eRx also during this transition period and will have this available in good time prior to the end of the transition period on 30/09/2023. Together with eRx we are defining the most effective mechanism by which MMEx prescribers will migrate to the new arrangements and we will communicate this to you in a subsequent update.

The DOHAC decision to award this contract to a single party with an extremely short timeline for implementation has caused great concern for many members of the e-prescribing eco-system. We welcome this very long awaited important notification which allows for an orderly transition to occur.